Erythrocin Stearate is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Erythromycin Stearate.
| Product ID | 55289-112_851a2f10-f4d6-e11f-e053-2991aa0aafbf |
| NDC | 55289-112 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Erythrocin Stearate |
| Generic Name | Erythromycin Stearate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2011-08-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA060359 |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | ERYTHROMYCIN STEARATE |
| Active Ingredient Strength | 250 mg/1 |
| Pharm Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2011-10-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA060359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-10-03 |
| Marketing Category | ANDA |
| Application Number | ANDA060359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-10-03 |
| Marketing Category | ANDA |
| Application Number | ANDA060359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-10-03 |
| Marketing Category | ANDA |
| Application Number | ANDA060359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-10-03 |
| Marketing Category | ANDA |
| Application Number | ANDA060359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-10-03 |
| Marketing Category | ANDA |
| Application Number | ANDA060359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-10-03 |
| Marketing Category | ANDA |
| Application Number | ANDA060359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-10-03 |
| Marketing Category | ANDA |
| Application Number | ANDA060359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-10-03 |
| Marketing Category | ANDA |
| Application Number | ANDA060359 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-10-03 |
| Ingredient | Strength |
|---|---|
| ERYTHROMYCIN STEARATE | 250 mg/1 |
| SPL SET ID: | 26f2704c-92ae-41c5-badc-dbebfb2eed35 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10544-594 | Erythrocin Stearate | Erythromycin Stearate |
| 10544-595 | Erythrocin Stearate | Erythromycin Stearate |
| 24338-106 | Erythrocin Stearate | ERYTHROMYCIN STEARATE |
| 50090-0025 | Erythrocin Stearate | ERYTHROMYCIN STEARATE |
| 55289-112 | Erythrocin Stearate | ERYTHROMYCIN STEARATE |